Strides Arcolab receives USFDA approval for Tacrolimus Capsules

23 Jul 2014 Evaluate

Strides Arcolab has received an approval from the United States Food & Drug Administration (USFDA) for Tacrolimus Capsules USP, 0.5 mg, 1 mg, and 5 mg. The US market for generic Tacrolimus is approximately $676 million, according to IMS data as on September 2013.

The product will be manufactured at the company’s Oral dosage facility at Bangalore and marketed directly by Strides in the US market.

Tacrolimus capsule is an immunosuppressant used for preventing organ rejection in certain patients following liver, kidney, or heart transplant. It may be used along with other medicines.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

791.45 -4.75 (-0.60%)
27-Jan-2026 14:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1626.70
Dr. Reddys Lab 1234.00
Cipla 1310.75
Zydus Lifesciences 887.70
Lupin 2125.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×